Sanofi AI Diabetes Companion

Personalizing insulin management through AI-driven insights and real-time patient data

An AI-powered system designed to optimize insulin dosing and improve outcomes for patients with Type 2 diabetes

An AI-powered system designed to optimize insulin dosing and improve outcomes for patients with Type 2 diabetes

Services

AI Product / Healthcare Innovation

Client

Year

2025

PROJECT'S OVERVIEW

This project introduces an AI-powered companion designed to improve insulin management for patients with Type 2 diabetes. By combining real-time health data with predictive analytics, the system delivers personalized dosing recommendations and actionable insights for both patients and clinicians. The solution addresses inefficiencies in traditional treatment methods while creating a more responsive, data-driven approach to diabetes care.
This project introduces an AI-powered companion designed to improve insulin management for patients with Type 2 diabetes. By combining real-time health data with predictive analytics, the system delivers personalized dosing recommendations and actionable insights for both patients and clinicians. The solution addresses inefficiencies in traditional treatment methods while creating a more responsive, data-driven approach to diabetes care.
This project introduces an AI-powered companion designed to improve insulin management for patients with Type 2 diabetes. By combining real-time health data with predictive analytics, the system delivers personalized dosing recommendations and actionable insights for both patients and clinicians. The solution addresses inefficiencies in traditional treatment methods while creating a more responsive, data-driven approach to diabetes care.

PROJECT FULL INFO

//

Let's Talk

I'm always open to discussing new opportunities, marketing strategy, or creative collaborations. Let's build something great together.

© 2026 Taha Mahmood

Marketing Strategist

Create a free website with Framer, the website builder loved by startups, designers and agencies.